The menstrual irregularities experienced by unvaccinated and unexposed women were consistent with those experienced by the ...

The candidates merge two existing vaccines that have demonstrated favourable tolerability through randomised controlled ...

Here’s what to know about the 2024-2025 vaccines — what’s available, how the updated versions are tested, how well each protects you, side effects and other safety information, the best time to get ...

New research published in the International Journal of Vaccine Theory, Practice, and Research has raised questions about the ...

A new nano-vaccine developed by TAU and the University of Lisbon offers a needle-free, room-temperature-storable solution ...

Two combination vaccine candidates for prevention of influenza and COVID-19 granted Fast Track designation in the USFirst non-mRNA combination ...

SARS-CoV-2 spike protein lingers in brain tissues for years. While vaccines cut accumulation by 50%, risks remain. Read more.

Researchers from Helmholtz Munich and Ludwig-Maximilians-Universität (LMU) have identified a mechanism that may explain the ...

TAU’s groundbreaking project has received competitive research grants from the Israel Innovation Authority and Merck under ...

Paris: The US Food and Drug Administration (USFDA) has granted Fast Track designation to two Sanofi combination vaccine ...

The following is a summary of “COVID-19 vaccination and cerebral small vessel disease progression - A prospective cohort ...

A new study reveals that the SARS-CoV-2 spike protein remains in brain-protective tissues and skull bone marrow for years after infection, potentially driving long COVID's neurological symptoms.